Beth E. Arnold

Partner - Boston

Bio photo for Beth Arnold
Download Media Photo

Contact Information

617.832.1294

617.832.7000

barnold@foleyhoag.com Download vCard

Beth Arnold, a partner in the firm’s intellectual property practice, is a U.S. registered patent attorney with over 20 years of experience in obtaining worldwide patent protection for pharmaceutical and biotechnology products. She has received recognition as a leading IP practitioner from Chambers USA, The Best Lawyers in America, Massachusetts SuperLawyers and Global Counsel 3000. Her clients, which include top-tier pharmaceutical companies, public and private biotechnology companies and medical research institutes, have described her as being "a force of nature in the biotech area in Boston" and as a patent attorney with "an impressive breadth and depth of experience." In addition to protecting intellectual assets, Beth prepares and negotiates agreements for developing and commercializing new products and technologies.

More »

Education:

  • Northeastern University School of Law, J.D.
  • Boston University, M.S. in Molecular Biology, cum laude
  • University of Rhode Island, B.S. in Biology, cum laude
  • Patent Considerations in Drug Development Agreements: 2012 and Beyond (May 2012)
  • A Practitioner's Guide to Petitions to Make Special, AIPLA Spring Meeting (May 11, 2005) 
  • Top five things to consider when negotiating an R&D partnership, MASS HIGH TECH (January 17-23, 2005)
  • Biogenerics may be inevitable, but will the feds be ready? BOSTON BUSINESS JOURNAL (March 2004)
  • Getting it Right the First Time: The Biomedical Patent Process, THE ART AND SCIENCE OF PATENT LAW (©Aspatore Books, Inside The Minds™ series) (2004)
  • Multiple patents, infringement cases add to cost of drugs, MASS HIGH TECH (March 2003)
  • Navigating Gene Patent Minefields, BIO IT WORLD (November 2002)
  • Potential Patent Obstacles on Horizon, BIO IT WORLD (August 2002)
  • Patenting Genes and Genetic Research Tools: Good or Bad for Innovation? ANNU. REV. GENOMICS HUM. GENET. 3:415-32 (2002)
  • Bioinformatic patents: Protecting path from data to drugs, BOSTON BUSINESS JOURNAL (June 2001)
  • Patent Strategies for Protecting Bioinformation: Consider Filing in Computer Examination Group, MIT FORUM REPORTER VOL.19 NO.6 (February 2001)
  • Chapter 2 - Patent Protection, BIOTECHNOLOGY: LAW, BUSINESS AND REGULATION, (Aspen Law & Business) (2000)
  • For Biotech Companies, IP Due Diligence Can Be Tricky, THE NATIONAL LAW JOURNAL (March 2000)

Foley Hoag Alerts & Updates

Honors

  • Listed in Best Lawyers in America in the field of  Litigation – Intellectual Property and Patent Law
  • Recognized in the 2013 MANAGING INTELLECTUAL PROPERTY's TOP 250 WOMEN in IP, a guide to the leading female intellectual property attorneys in the United States
  • Listed in MASSACHUSETTS SUPER LAWYERS (2004-2014)
  • Ranked by CHAMBERS USA: AMERICA'S LEADING LAWYERS FOR BUSINESS as one of Massachusetts' leading intellectual property lawyers (2004-2014)
  • Ranked as a “highly recommended” Life Sciences: Intellectual Property attorney in Boston by GLOBAL COUNSEL 3000 (2001-2005)

Involvement

  • The Biotechnology Industry Organization (BIO), Member
  • The Massachusetts Biotechnology Council (MBC), Member
  • The Licensing Executive Society (LES), Member
  • American Intellectual Property Law Association (AIPLA), Member
  • Boston Patent Law Association (BPLA), Member
  • American Bar Association (ABA), Member
  • Boston Bar Association (BBA), Member

     

  • American Conference Institute (ACI) 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements: Allocating Rights, Responsibilities & Rewards in Licensing, Strategic Alliances and Partnering Deals, "Setting the Stage for Success by Choosing the Right Partner and Conducting Effective Due Diligence," November 13, 2008
  • AIPLA Spring Meeting, “A Practitioner’s Guide to Petitions to Make Special: How to Effectively Expedite Examination of Your Patent Application,” May 11, 2005
  • Springboard Enterprise Venture Capital Forum Alumni Celebration, “Partnering for Growth - Not Creating Competitors,” March 16, 2005
  • LES 40th Annual Meeting, “The Negotiation and Drafting of Collaborative Drug Development Agreements,” October 18, 2004
  • IBC Life Sciences Protecting Biotech Inventions Conference, “Patent Protecting Biological Processes in the U.S.,” Zurich Switzerland, September 21-23, 2004
  • MassMEDIC: Managing Your MedTech Company’s Intellectual Property, “Patent Claim Strategies to Maximize Value,” June 15, 2004
  • BioIT World 2004 Annual Meeting, Boston, MA, “The Druggable Genome: What to Patent?,” March 2004
  • The Licensing Executive Society (LES) Annual Meeting, Chicago, IL, “Patents and Biological Materials: Do You Really Own What You Think?”, September 2002
  • Compaq Computer Corporation and Whitehead Institute Center for Genome Research sponsored seminar, 21st Century Life Science Technology Revolution, “Patenting Genes and Genetic Research Tools,” June 10-12, 2002
  • Boston College Health Law Series, “Commercializing Medical Technologies,” October 2000
  • American Society of Law, Medicine & Ethics, Boston, MA, “The Impact of Patent Law on the Dissemination of Genetic Tests,” September 2000
  • McKinsey & Company Annual Healthcare Meeting, Boca Raton, FL, “Patent Considerations Pertaining to Genomic Technologies,” February 2000
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts

Court Admissions

  • U.S. Patent Trademark Office (Agency)
  • U.S. District Court for the District of Massachusetts